Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated
Rheumatology

Navigating IgG4-Related Retroperitoneal Fibrosis: A Patient's Guide

At a Glance

IgG4-related retroperitoneal fibrosis (IgG4-RPF) is a rare but highly treatable immune condition that causes dense scar tissue to form behind the digestive organs. Effective management requires a team of specialists, including a rheumatologist, urologist, and nephrologist.

If you or a loved one has just been diagnosed with IgG4-related retroperitoneal fibrosis (IgG4-RPF), you have likely never heard of this condition before. It is a rare, complex disease, and receiving this diagnosis often comes after a frustratingly long journey of unexplained pain and confusing test results.

Take a deep breath. While this is a serious condition, it is highly treatable.

IgG4-RPF is a fibro-inflammatory condition [1][2]. This means that a specific part of your immune system is confused, causing dense, tumor-like scar tissue (fibrosis) to form in the retroperitoneum—the space deep in the back of your abdomen behind your digestive organs. Because this disease is rare, your local primary care doctor or local specialists may have limited experience treating it.

The most important thing you can do right now is get informed. This resource is designed to stop the panic spiral and equip you with the knowledge you need to advocate for yourself. It translates complex medical jargon into clear, actionable information so you can confidently partner with your medical team.

In this guide, we will cover:

Common questions in this guide

What is IgG4-related retroperitoneal fibrosis (IgG4-RPF)?
It is a rare fibro-inflammatory condition where a specific part of the immune system becomes confused. This causes dense, tumor-like scar tissue to form in the retroperitoneum, which is the space deep in the back of your abdomen behind your digestive organs.
What kind of doctors treat IgG4-RPF?
Because it is a complex and rare disease, you will typically need a multidisciplinary care team. This core team usually includes a rheumatologist, a urologist, and a nephrologist to manage the inflammation and protect your organs.
How should I keep track of my medical records for IgG4-RPF?
Patients with rare diseases often need to act as their own advocates. It is highly recommended to keep a dedicated binder or digital folder to track all of your lab results, imaging discs, and pathology reports so you can easily share them with your different specialists.
Is IgG4-related retroperitoneal fibrosis a type of cancer?
No, it is not cancer. While it can cause dense, tumor-like masses of scar tissue to form in the abdomen, it is a fibro-inflammatory immune condition rather than a malignancy, and it is highly treatable.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the rarity of IgG4-RPF, how many cases have you or your clinic managed in the past year?
  2. 2.Which specific medical specialists (e.g., rheumatologist, urologist, nephrologist) do I need on my core care team?
  3. 3.Will you coordinate directly with my other specialists, or do I need to act as the primary messenger for my test results?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (2)
  1. 1

    IgG4-related retroperitoneal fibrosis presenting as a peripancreatic mass: a case series.

    Badshah MB, Khan QA, Kazi N, et al.

    Annals of medicine and surgery (2012) 2025; (87(1)):36-42 doi:10.1097/MS9.0000000000002749.

    PMID: 40109592
  2. 2

    Title not available

    Le Joncour A, Saadoun D, Cacoub P

    La Revue de medecine interne 2020; (41(12)):822-828 doi:10.1016/j.revmed.2020.06.013.

    PMID: 32727694

This page provides an educational overview of IgG4-related retroperitoneal fibrosis. Always consult your rheumatologist, urologist, or primary care doctor for specific medical advice and treatment coordination.

Get notified when new evidence is published on IgG4-related retroperitoneal fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.